Aligos Therapeutics, Inc. (ALGS)
NASDAQ: ALGS · Real-Time Price · USD
5.26
-0.24 (-4.36%)
Sep 10, 2026, 11:34 AM EDT - Market open
Aligos Therapeutics Market Cap
Aligos Therapeutics has a market cap or net worth of $32.85 million as of September 10, 2026. Its market cap has decreased by -52.41% in one year.
Market Cap
32.85M
Enterprise Value
5.97M
1-Year Change
-52.41%
Ranking
Category
Stock Price
$5.26
ChartMarket Cap Chart
Since the IPO on October 16, 2020, Aligos Therapeutics's market cap has decreased from $553.35M to $32.85M, a decrease of -94.06%. That is a compound annual growth rate of -38.02%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 10, 2026 | 32.85M | -42.73% |
| Dec 31, 2025 | 57.35M | -61.21% |
| Dec 31, 2024 | 147.87M | 197.20% |
| Dec 29, 2023 | 49.75M | 21.95% |
| Dec 30, 2022 | 40.80M | -91.93% |
| Dec 31, 2021 | 505.85M | -52.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Metagenomi Therapeutics | 44.20M |
| Grace Therapeutics | 44.18M |
| Karyopharm Therapeutics | 40.60M |
| Mereo BioPharma Group | 39.92M |
| Filana Therapeutics | 39.62M |
| Lite Strategy | 38.79M |
| CervoMed | 38.70M |
| NextCure | 35.79M |